Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin.
Roisin BavaliaIngrid M BistervelsWim G BoersmaIsabelle QuéréDominique BrisotNicolas FalvoDominique StephanFrancis CouturaudSebastian SchellongJan Beyer-WestendorfKarine MontaclairWaleed GhanimaMarije Ten WoldeMichiel CoppensEmile FerrariOlivier SanchezPatrick CarrollPierre-Marie RoySusan R KahnKarina MeijerSimone BirocchiMichael J KovacsAmanda HugmanHugo Ten CateHilde Skuterud WikGilles PernodMarie-Antoinette Sevestre-PietriMichael A GrossoMinggao ShiYong LinBarbara A HuttenPeter VerhammeSaskia Middeldorpnull nullPublished in: Research and practice in thrombosis and haemostasis (2021)
Our findings indicate that patients with an index PE treated with edoxaban or warfarin have a similar long-term QoL. Since our study was a follow-up study from a well-controlled clinical trial setting, future studies should be designed in a daily clinical practice setting. We suggest a longitudinal design for investigation of changes in QoL over time.